FDA Approved: ZILRETTA — Original Application (Pacira Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide, under its original NDA. It is intended for intra-articular treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

ORIG AP for ZILRETTA (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION)